By 2019, intrauterine device market is projected to be worth more than $4 Billion as awareness about IUDs as one of the most beneficial contraceptives goes up and is supported by factual PR exercises. In 2015, global contraceptives market was estimated to be over $9 Billion and stood firm as the second largest women’s health market segment. For the next 4 to 5 years, it is estimated that the need for secure (because of growing fear of STDs, unintended pregnancies) and cost effective (initial IUD offerings were too costly) contraception will help the intrauterine device market grow steadily across the globe.
In the US, intrauterine devices are slowly gaining traction with leading medical organizations now recommending IUDs as first-line contraceptive choice for women, which earlier was the not the case. Europe, Middle East and Africa (EMEA) historically lead the intrauterine device market, followed by Americas and Asia Pacific. With a majority of European women opting for contraceptives in order to avoid unplanned pregnancies and females in Africa trying to save themselves from diseases, the knowledge about IUDs is spreading via government efforts, NGO programs as well as intrauterine device market companies creating awareness via their social marketing efforts. Companies are focusing on improvised IUD product offerings such as the fourth generation IUDs with a life span of 25 years. With one of the highest efficacy rates in controlling pregnancies, these new intrauterine devices are useful as ultra-long, efficient and reversible long-acting reversible contraceptives (LARC).
APAC is expected to grow at one of the fastest rates for IUDs market in coming years due to its population, increasing disposable income and lifestyle changes bringing rising awareness of contraceptives and hence intrauterine devices. Though Americas is the second largest market for IUDs, the growth is forecast to be steady / stagnant with focus moving towards innovating products that help ensure consistency in growth. Overall, the industry is competitive, yet susceptible to various challenges (R&D, technical, etc), which can enable inorganic growth within the market. As Technavio says, “local and regional vendors in this market compete on the basis of product price, quality, innovation, service, reputation, distribution, and promotion to gain maximum market traction during the forecast period”.
Several studies emphasize the potential of long-acting reversible contraceptive methods, including Intrauterine Devices and subdermal implants, to reduce unintended pregnancy rates. These studies show that the risk of pregnancy among women using long-acting methods is much lower than among those relying on shorter-acting methods such as condoms and the birth control pill.
The Global Intrauterine Device Industry 2016 Market Research Report now available with eMarketOrg.com is of 152 pages and IUD market analysis provided in this study is supported with 174 data tables and figures. Geographically, this intrauterine devices report cover data for United States, EU, China and Japan. Companies like Bayer Healthcare LLC, Wuxi Tianyi Medical Equipment Co., Ltd, Nanjing Health Medical Technology Co., Ltd, CHONGQING MEDICAL EQUIPMENT FACTORY CO., LTD, Shanghai Medical Suture Needle Factory Co., Ltd and many others are discussed in the report available at http://emarketorg.com/pro/global-intrauterine-device-industry-2016-market-research-report/ .